The real prize of direct oral anticoagulant blockbuster
The real prize of direct oral anticoagulant blockbuster
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group Ltd and British Cardiovascular Society
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd and British Cardiovascular Society
Subjects
More information
Scope and Contents
Contents
Direct oral anticoagulants (DOACs)—apixaban, dabigatran, edoxaban and rivaroxaban—turned out to be convenient and to bear a lower risk of intracerebral haemorrhage3 compared with vitamin K antagonists overall resulting in a net benefit for patients.4 Widespread use in patients with atrial fibrillation—particularly among those who did not receive an...
Alternative Titles
Full title
The real prize of direct oral anticoagulant blockbuster
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2456412346
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2456412346
Other Identifiers
ISSN
1355-6037
E-ISSN
1468-201X
DOI
10.1136/heartjnl-2020-318092
